DGAP-News: RHÖN-KLINIKUM AG: Accounts press conference in Frankfurt am Main on 25 April 2013 (english)

RHÖN-KLINIKUM AG: Accounts press conference in Frankfurt am Main on 25 April

2013



DGAP-News: RHÖN-KLINIKUM AG / Key word(s): Final Results

RHÖN-KLINIKUM AG: Accounts press conference in Frankfurt am Main on 25

April 2013



25.04.2013 / 07:00



---------------------------------------------------------------------



Annual results 2012

Renewed increase in patients treated of 12.2 % is evidence of confidence

in the quality of care and medical capability

9.0 % revenue growth in a challenging regulatory environment

Growth driven by the integration of the HSK in Wiesbaden

42.9 % decline in earnings, mainly due to setbacks in the UKGM

restructuring and other non-recurring charges



Results of Q1 2013

Increase of 60,781 or 10.0 % in number of patients to a total of 670,677

cases underlines a good start to the new financial year

Revenue grows by 10.2 % to EUR752.2 million

Consolidated net profit decreases by EUR9.8 million or 28.7 % to EUR24.3

million

EBIT falls by EUR8.6 million or 17.7 % to EUR39.9 million

EBITDA shrinks by EUR6.9 million or 8.4 % to EUR74.9 million





In 2012, nearly 2.6 million patients were treated in the Group's hospitals.

In the same period, revenue rose to EUR2.86 billion. Due to setbacks in the

restructuring of the University Hospital Gießen and Marburg (UKGM),

non-recurring charges connected to the Fresenius takeover bid, increased

regulatory pressure and a negative contribution from Dr. Horst Schmidt

Kliniken Wiesbaden (HSK), which was consolidated for the first time in

2012, consolidated net profit fell 42.9 % to EUR92.0 million. EBITDA,

adjusted for the effect of the Siemens compensation payment with regard to

'PTZ Marburg' in the 2011 financial year, declined by 13.7 % to EUR291.5

million year-on-year, and EBIT fell 29.5 % to EUR150.3 million.

'Despite the eventful and difficult 2012 financial year, RHÖN-KLINIKUM AG's

revenue and patient numbers are rising steadily. The continuing

attractiveness of our services is clearly strengthened by this show of

confidence. Nonetheless, the cost situation overall is unsatisfactory,'

said Dr Martin Siebert, Chairman of the Board of Management at

RHÖN-KLINIKUM AG.

At this year's Annual General Meeting on 12 June 2013, the Board of

Management and Supervisory Board will propose a dividend distribution of

EUR0.25 (previous year: EUR0.45) per share entitled to dividend (DE

0007042301; 138,232,000 shares).



Jobs 2012

As of 31 December 2012, RHÖN-KLINIKUM AG employed 43,059 people in ten

German states. That is once again more than the year before. In many

regions, the hospitals of the RHÖN-KLINIKUM Group are among the largest

employers.



Results of Q1 2013

670,677 patients were treated in the first three months of the current

financial year (+10.0 %). Revenue grew to EUR752.2 million (+10.2 %).

Consolidated net profit fell by 28.7 % to EUR24.3 million. EBITDA decreased

to EUR74.9 million (-8.4 %). EBIT declined to EUR39.9 million and is thus

17.7 % lower than in the previous year.



Outlook for 2013

The company has confirmed its forecast for 2013 as a whole. In 2013,

RHÖN-KLINIKUM AG expects revenue of EUR3.03 billion, plus or minus 2.5 %.

This revenue target is accompanied by an EBITDA forecast of EUR325 million

and a consolidated net profit forecast of EUR110 million, each with a

fluctuation range of +/- 5 %.



'We are confident that the structural, procedural and staffing measures of

recent months have laid the first important foundations for making the

company more competitive, so that RHÖN-KLINIKUM AG can return to where we

believe it belongs: at the very top of the market. The institutional basis

for this will be provided by a systematic Group-wide optimisation

programme, currently being launched, which relates to our traditional

strengths and also enriches our tried-and-tested business model with fresh

stimulus,' said Dr Martin Siebert, Chairman of the Board of Management at

RHÖN-KLINIKUM AG.



'The goal is clear: step by step, we want to rebuild the company as an

integrated health group, in which knowledge, skills, technologies and

processes are first and foremost systematically shared and closely

interlinked to a much greater degree than before. In the future, a

strengthened University Hospital Gießen and Marburg will play a more

important role as a 'medical technology hub' for all Group hospitals,' the

Board of Management Chairman said.



Wiesbaden's Dr. Horst Schmidt Kliniken (HSK) is being integrated into the

company 'energetically': 'We are on budget and expect to achieve the first

positive monthly results in the third quarter of this year. Achieving our

profitability targets is therefore not an end in itself, but rather the

necessary financial requirement not only to uphold our long-held credo of

affordable top-quality medical care for everyone, but also to improve on

it,' said Siebert.





End of Corporate News



---------------------------------------------------------------------



25.04.2013 Dissemination of a Corporate News, transmitted by DGAP - a

company of EquityStory AG.

The issuer is solely responsible for the content of this announcement.



DGAP's Distribution Services include Regulatory Announcements,

Financial/Corporate News and Press Releases.

Media archive at www.dgap-medientreff.de and www.dgap.de



---------------------------------------------------------------------





Language: English

Company: RHÖN-KLINIKUM AG

Schlossplatz 1

97616 Bad Neustadt a.d.Saale

Germany

Phone: +49 (0)9771 - 65-0

Fax: +49 (0)9771 - 97 467

E-mail: rka@rhoen-klinikum-ag.com

Internet: www.rhoen-klinikum-ag.com

ISIN: DE0007042301

WKN: 704230

Indices: MDAX

Listed: Regulierter Markt in Frankfurt (Prime Standard), München;

Freiverkehr in Berlin, Düsseldorf, Hamburg, Stuttgart





End of News DGAP News-Service

---------------------------------------------------------------------

208463 25.04.2013









Weitere Informationen: www.dpa-AFX.de